In this study the levels of visfatin and PAI-1 were higher in overweight, ObI and ObII/III groups(Table 1), in agreement with previous reports, suggesting that these proteins could be a promising biomarker in cardiovascular disease related to metabolism alterations. The gene discussed is NAMPT; the disease is cardiovascular disorder.